Multi-use disposable system and syringe therefor

Information

  • Patent Grant
  • 11738152
  • Patent Number
    11,738,152
  • Date Filed
    Monday, June 12, 2017
    7 years ago
  • Date Issued
    Tuesday, August 29, 2023
    10 months ago
Abstract
A syringe including a syringe body extending from a proximal end to a distal end, and a stabilizing element provided on the distal end of the syringe body, a portion of the stabilizing element extending substantially perpendicular to a longitudinal axis of the syringe body. A multi-use disposable set (MUDS) includes a plurality of syringes, each syringe having a syringe body, a proximal end, a distal end spaced apart from the proximal end along a longitudinal axis of the syringe body, a stabilizing element provided on the distal end, a portion of the stabilizing element extending substantially perpendicular to the longitudinal axis of the syringe body, and a manifold in fluid communication with the distal end of each of the plurality of syringes.
Description
BACKGROUND
Field of the Technology

This disclosure relates, generally, to the field of multi-fluid delivery systems and, more particularly, to syringes used in a multi-use disposable set of a multi-fluid delivery system.


Description of Related Art

In many medical diagnostic and therapeutic procedures, a medical practitioner, such as a physician, injects a patient with one or more medical fluids. In recent years, a number of medical fluid delivery systems for pressurized injection of fluids, such as a contrast solution (often referred to simply as “contrast”), a flushing agent, such as saline, and other medical fluids, have been developed for use in procedures such as angiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), positron emission tomography (PET), and other imaging procedures. In general, these medical fluid delivery systems are designed to deliver a preset amount of fluid at a preset flow rate.


In some injection procedures, the medical practitioner places a catheter or needle into a vein or artery of the patient. The catheter or needle is connected to either a manual or an automatic fluid injector system by way of tubing, and a connector that interfaces with the fluid injector system. Automatic fluid injector systems typically include at least one syringe connected to at least one fluid injector having, for example, a powered linear piston. The at least one syringe includes, for example, a source of contrast and/or a source of flushing fluid. The medical practitioner enters settings into an electronic control system of the fluid injector for a fixed volume of contrast and/or saline and a fixed rate of injection for each. A single-use disposable set connector and associated tubing is connected to the fluid injector system for delivering one or more fluids to the patient.


While various manual and automatic fluid delivery systems are known in the medical field, improved multi-fluid delivery systems adapted for use in medical diagnostic and therapeutic procedures where one or more fluids are supplied to a patient during such procedures continue to be in demand. Additionally, improved syringes that may be used with multi-fluid delivery systems for facilitating a delivery of one or more fluids to a patient are also desired in the medical field. The medical field continues to demand improved medical devices and systems used to supply fluids to patients during various medical procedures.


SUMMARY

In view of the foregoing, a need exists for an improved multi-use disposable set and syringe therefor that allows for more stable positioning of the syringe within a fluid injector. Further, there is a need for an improved syringe that prevents a situation where force applied to the syringe(s) of the multi-use disposable set during fluid deliver or force applied when engaging the multi-use disposable set into the injector may push or dislodge the multi-use disposable set into an off-center, tilted, or angled position within the fluid delivery system. In such an off-center, tilted, or angled position, additional for may cause fluid leakage around the plunger, breakage of the multi-use disposable set, or damage to portions of the fluid injector assembly.


Therefore, a multi-use disposable set and syringe therefor configured to address some or all of these needs are provided herein. According to a first example of the disclosure, a syringe may include a syringe body having a proximal end and a distal end spaced apart from the proximal end along a longitudinal axis, a cone portion and a nozzle extending distally from the distal end of the syringe body, and a stabilizing element provided on the distal end of the syringe body, the stabilizing element having a support surface extending substantially perpendicular to the longitudinal axis of the syringe body.


The stabilizing element may be integrally formed on the syringe body. The stabilizing element may include a ring provided on an outer circumferential surface of the distal end of the syringe body. The stabilizing element may include a sleeve provided on an outer circumferential surface of the syringe body. The sleeve may extend from the proximal end of the syringe body to the distal end of the syringe body. The stabilizing element may include a portion of the syringe body that extends axially along a longitudinal axis of the syringe body and protrudes from the cone portion on a distal end of the syringe body. The stabilizing element may include a planar portion and at least two webs connected to the cone portion and the planar portion. The stabilizing element may include at least two substantially triangular extensions including an upper planar surface and a bottom surface connected to the cone portion. The upper planar surface may extend substantially perpendicularly relative to the longitudinal axis of the syringe body. The stabilizing element may include a first planar portion connected to the cone portion via at least one web, and a second planar portion connected to the cone portion via at least one web. The planar portions may be separated from one another on the cone portion. The planar portions may extend substantially perpendicularly relative to the longitudinal axis of the syringe body. The planar portions may be positioned adjacent a discharge conduit defined in the distal end of the syringe body.


In another example of the disclosure, a multi-use disposable set (MUDS) may include a plurality of syringes, each syringe having a syringe body, proximal end, a distal end spaced apart from the proximal end along a longitudinal axis of the syringe body, a cone portion and a nozzle extending distally from the distal end of the syringe body, a stabilizing element provided on the distal end, the stabilizing element having a support surface extending substantially perpendicular to the longitudinal axis of the syringe body, and a manifold in fluid communication with the distal end of each of the plurality of syringes.


The stabilizing element may be integrally formed on the syringe body. The stabilizing element may include a ring provided on an outer circumferential surface of the distal end of the syringe body. The stabilizing element may include a sleeve provided on an outer circumferential surface of the syringe body. The sleeve may extend from the proximal end of the syringe body to the distal end of the syringe body. The stabilizing element may include a portion of the syringe body that extends axially along a longitudinal axis of the syringe body and protrudes from the cone portion on a distal end of the syringe body. The stabilizing element may include a planar portion and at least two webs connected to the cone portion and the planar portion. The stabilizing element may include at least two substantially triangular extensions including an upper planar surface and a bottom surface connected to the cone portion. The upper planar surface may extend substantially perpendicularly relative to the longitudinal axis of the syringe body. The stabilizing element may include a first planar portion connected to the cone portion via at least one web, and a second planar portion connected to the cone portion via at least one web. The planar portions may be separated from one another on the cone portion. The planar portions may extend substantially perpendicularly relative to the longitudinal axis of the syringe body. The planar portions may be positioned adjacent a discharge conduit defined in the distal end of the syringe body.


Further examples will now be described in the following numbered clauses.


Clause 1: A syringe, comprising a syringe body having a proximal end and a distal end spaced apart from the proximal end along a longitudinal axis; a cone portion and a nozzle extending distally from the distal end of the syringe body; and a stabilizing element provided on the distal end of the syringe body, the stabilizing element having a support surface extending substantially perpendicular to the longitudinal axis of the syringe body.


Clause 2: The syringe of Clause 1, wherein the stabilizing element is integrally formed on the syringe body.


Clause 3: The syringe of Clause 1 or Clause 2, wherein the stabilizing element comprises a ring provided on an outer circumferential surface of the distal end of the syringe body.


Clause 4: The syringe of any of Clauses 1-3, wherein the stabilizing element comprises a sleeve provided on an outer circumferential surface of the syringe body, the sleeve extending from the proximal end of the syringe body to the distal end of the syringe body.


Clause 5: The syringe of any of Clauses 1-4, wherein the stabilizing element comprises a portion of the syringe body that extends axially along a longitudinal axis of the syringe body and protrudes from the cone portion on a distal end of the syringe body.


Clause 6: The syringe of any of Clauses 1-5, wherein the stabilizing element comprises a planar portion and at least two webs connected to the cone portion and the planar portion.


Clause 7: The syringe of any of Clauses 1-6, wherein the stabilizing element comprises at least two substantially triangular extensions including an upper planar surface and a bottom surface connected to the cone portion.


Clause 8: The syringe of Clause 7, wherein the upper planar surface extends substantially perpendicularly relative to the longitudinal axis of the syringe body.


Clause 9: The syringe of any of Clauses 1-8, wherein the stabilizing element comprises a first planar portion connected to the cone portion via at least one web, and a second planar portion connected to the cone portion via at least one web, and wherein the planar portions are separated from one another on the cone portion.


Clause 10: The syringe of Clause 9, wherein the planar portions extend substantially perpendicularly relative to the longitudinal axis of the syringe body, and wherein the planar portions are positioned adjacent to a discharge conduit defined in the distal end of the syringe body.


Clause 11: A multi-use disposable set (MUDS) comprising: a plurality of syringes, each syringe having a syringe body, a proximal end, a distal end spaced apart from the proximal end along a longitudinal axis of the syringe body, a cone portion and a nozzle extending distally from the distal end of the syringe body, and a stabilizing element provided on the distal end, the stabilizing element having a support surface extending substantially perpendicular to the longitudinal axis of the syringe body; and a manifold in fluid communication with the distal end of each of the plurality of syringes.


Clause 12: The MUDS of Clause 11, wherein the stabilizing element is integrally formed on the syringe body.


Clause 13: The MUDS of Clause 11 or Clause 12, wherein the stabilizing element comprises a ring provided on an outer circumferential surface of the distal end of the syringe body.


Clause 14: The MUDS of any of Clauses 11-13, wherein the stabilizing element comprises a sleeve provided on an outer circumferential surface of the syringe body, the sleeve extending from the proximal end of the syringe body to the distal end of the syringe body.


Clause 15: The MUDS of any of Clauses 11-14, wherein the stabilizing element comprises a portion of the syringe body that extends axially along a longitudinal axis of the syringe body and protrudes from the cone portion on a distal end of the syringe body.


Clause 16: The MUDS of any of Clauses 11-15, wherein the stabilizing element comprises a planar portion and at least two webs connected to the cone portion and the planar portion.


Clause 17: The MUDS of any of Clauses 11-16, wherein the stabilizing element comprises at least two substantially triangular extensions including an upper planar surface and a bottom surface connected to the cone portion.


Clause 18: The MUDS of Clause 17, wherein the upper planar surface extends substantially perpendicularly relative to the longitudinal axis of the syringe body.


Clause 19: The MUDS of any of Clauses 11-18, wherein the stabilizing element comprises a first planar portion connected to the cone portion via at least one web, and a second planar portion connected to the cone portion via at least one web, and wherein the planar portions are separated from one another on the cone portion.


Clause 20: The MUDS of Clause 19, wherein the planar portions extend substantially perpendicularly relative to the longitudinal axis of the syringe body, and wherein the planar portions are positioned adjacent to a discharge conduit defined in the distal end of the syringe body.


These and other features and characteristics of multi-use disposable sets and syringes therefor, as well as the methods of operation and functions of the related elements of structures and the combination of parts and economies of manufacture, will become more apparent upon consideration of the following description and the appended claims with reference to the accompanying drawings, all of which form a part of this specification, wherein like reference numerals designate corresponding parts in the various figures. It is to be expressly understood, however, that the drawings are for the purpose of illustration and description only, and are not intended as a definition of the limits of the disclosure. As used in the specification and the claims, the singular form of “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A is a perspective view of a multi-fluid delivery system, according to one example of the disclosure;



FIG. 1B is a perspective view of the multi-fluid delivery system of FIG. 1A with an access panel in an open position;



FIG. 2 is a schematic view of various fluid paths within the multi-fluid delivery system of FIG. 1A;



FIG. 3A is a perspective view of a multi-use disposable set (MUDS) during insertion into a receiving slot on a multi-fluid delivery system;



FIG. 3B is a side view of the MUDS of FIG. 3A;



FIG. 4A is a perspective view of the MUDS installed into the receiving slot on the multi-fluid delivery system of FIG. 3A;



FIG. 4B is a side view of the MUDS of FIG. 4A;



FIG. 4C is a cross-sectional view of the MUDS of FIG. 4A;



FIG. 5 is a perspective view of a MUDS having a plurality of syringes according to one example of the present disclosure;



FIG. 6A is a perspective view of a single syringe configured for use with the MUDS according to a one example of the present disclosure;



FIG. 6B is a perspective view of a single syringe configured for use with the MUDS according to a another example of the present disclosure;



FIG. 6C is a perspective view of a single syringe configured for use with the MUDS according to a another example of the present disclosure;



FIG. 6D is a perspective view of a single syringe configured for use with the MUDS according to a another example of the present disclosure;



FIG. 6E is a perspective view of a single syringe configured for use with the MUDS according to another example of the present disclosure;



FIG. 7A is a bottom view of the top plate associated with the injector for restraining the MUDS according to one example of the present disclosure; and



FIG. 7B is a top view of the top plate associated with the injector for restraining the MUDS according to one example of the present disclosure.





DETAILED DESCRIPTION

For purposes of the description hereinafter, the terms “upper”, “lower”, “right”, “left”, “vertical”, “horizontal”, “top”, “bottom”, “lateral”, “longitudinal”, and derivatives thereof shall relate to the disclosure as it is oriented in the drawing figures. When used in relation to a syringe of a fluid injector of a MUDS, the term “proximal” refers to a portion of a syringe nearest a piston element when the MUDS is installed on a fluid injector system. When used in relation to a syringe of a MUDS, the term “distal” refers to a portion of a syringe nearest to a delivery nozzle or any portion of a syringe from a delivery nozzle to at least a midway point on a body of the syringe. It is also to be understood that the specific devices and processes illustrated in the attached drawings, and described in the following specification, are simply exemplary examples of the disclosure. Hence, specific dimensions and other physical characteristics related to the examples disclosed herein are not to be considered as limiting.


Referring to the drawings in which like reference characters refer to like parts throughout the several views thereof, the present disclosure is generally directed to a multi-fluid medical injector/injection system 100 (hereinafter “fluid injector system 100”) having a multi-use disposable set (MUDS) 130 configured for delivering fluid to a patient using a single-use disposable set (SUDS) connector. The fluid injector system 100 includes multiple components as individually described herein. Generally, the fluid injector system 100 has a powered injector administrator or device and a fluid delivery set intended to be associated with the injector to deliver one or more fluids from one or more multi-dose containers under pressure into a patient, as described herein. The various devices, components, and features of the fluid injector system 100, and the fluid delivery set associated therewith are likewise described in detail herein.


With reference to FIG. 1A, the fluid injector system 100 includes an injector housing 102 having opposed lateral sides 104, a distal or upper end 106, and a proximal or lower end 108. In some examples, the housing 102 may be supported on a base 110 having one or more wheels 112 for rotatable and movable support of the housing 102 on a floor surface. The one or more wheels 112 may be lockable to prevent the housing 102 from inadvertently moving once positioned at a desired location. At least one handle 114 may be provided to facilitate moving and positioning the fluid injector system 100. In other examples, the housing 102 may be removably or non-removably secured to a fixed surface, such as a floor, ceiling, wall, or other structure. The housing 102 encloses the various mechanical drive components, electrical and power components necessary to drive the mechanical drive components, and control components, such as electronic memory and electronic control devices (hereinafter electronic control device(s)), used to control operation of reciprocally movable piston elements 103 (shown in FIG. 2) associated with the fluid injector system 100 described herein. Such piston elements 103 may be reciprocally operable via electro-mechanical drive components such as a ball screw shaft driven by a motor, a voice coil actuator, a rack-and-pinion gear drive, a linear motor, and the like. In some examples, at least some of the mechanical drive components, electrical and power components, and control components may be provided on the base 110.


With reference to FIG. 1B, and with continued reference to FIG. 1A, the fluid injector system 100 has at least one door 116 that encloses at least some of the mechanical drive components, electrical and power components, and control components. The door 116 is desirably movable between an open position (shown in FIG. 1B) and a closed position (shown in FIG. 1A). In some examples, the door 116 may be lockable.


The fluid injector system 100 further includes at least one bulk fluid connector 118 for connection with at least one bulk fluid source 120. In some examples, a plurality of bulk fluid connectors 118 may be provided. For example, as shown in FIGS. 1A and 1B, three bulk fluid connectors 118 may be provided in a side-by-side or other arrangement. In some examples, the at least one bulk fluid connector 118 may be a spike configured for removably connecting to the at least one bulk fluid source 120, such as a vial, bottle, or a bag. The at least one bulk fluid connector 118 may have a reusable or non-reusable interface with each new bulk fluid source 120. The at least one bulk fluid connector 118 may be formed on the multi-use disposable set, as described herein. The at least one bulk fluid source 120 may be configured for receiving a medical fluid, such as saline, contrast solution, or other medical fluid, for delivery to the fluid injector system 100. The housing 102 may have at least one support member 122 for supporting the at least one bulk fluid source 120 once it is connected to the fluid injector system 100.


With reference to FIG. 1A, the fluid injector system 100 includes one or more user interfaces 124, such as a graphical user interface (GUI) display window. The user interface 124 may display information pertinent to a fluid injection procedure involving the fluid injector system 100, such as flow rate, fluid pressure, and volume remaining in the at least one bulk fluid source 120 connected to the fluid injector system 100. The user interface 124 may be a touch screen GUI that allows an operator to input commands and/or data for operation of the fluid injector system 100. In some examples, the user interface 124 may be a tablet that is detachably connected to the housing 102 and is in wired or wirelessly linked communication with the housing 102. Additionally, the fluid injector system 100 and/or user interface 124 may include at least one control button 126 for tactile operation by an attendant operator of the fluid injector system 100. In certain examples, the at least one control button may be part of a keyboard for inputting commands and/or data by the operator. The at least one control button 126 may be hard-wired to the electronic control device(s) associated with the fluid injector system 100 to provide direct input to the electronic control device(s). The at least one control button 126 may also be graphically part of the user interface 124, such as a touch screen. In either arrangement, the at least one control button 126 desirably provides certain individual control features to the attendant operator of the fluid injector system 100, such as but not limited to: (1) acknowledging that a multi-use disposable set (MUDS) 130 has been loaded or unloaded; (2) locking/unlocking of the MUDS 130; (3) filling/purging of the fluid injector system 100, inputting information and/or data related to the patient and/or injection procedure; and (4) initiating/stopping an injection procedure. The user interface 124 and/or any electronic processing units associated with the fluid injector system 100 may be wired or wirelessly connected to an operation and/or data storage system such as a hospital network system.


With reference to FIG. 1B, the fluid injector system includes the MUDS 130 that is removably connected to the fluid injector system 100 for delivering one or more fluids from the one or more bulk fluid sources 120 to the patient. The fluid injector system 100 includes at least one slot or access port 192 for releasably connecting a SUDS to the MUDS 130, as described herein. The MUDS 130 may include one or more syringes or pumps 132. In some examples, the number of syringes 132 may correspond to the number of bulk fluid sources 120. For example, with reference to FIG. 1B, the MUDS 130 has three syringes 132 in a side-by-side arrangement such that each syringe 132 is fluidly connectable to one of the bulk fluid sources 120. In some examples, one or two bulk fluid sources 120 may be connected to one or more syringes 132 of the MUDS 130. Each syringe 132 may be fluidly connectable to one of the bulk fluid sources 120 by a corresponding bulk fluid connector 118 and an associated MUDS fluid path 134. The MUDS fluid path 134 may have a spike element that connects to the bulk fluid connector 118. In some examples, the bulk fluid connector 118 may be provided directly on the MUDS 130.


With further reference to FIGS. 2-3A, the MUDS 130 is removably connectable to the housing 102 of the fluid injector system 100. With specific reference to FIG. 3B, the MUDS 130 further includes a frame 154 receiving at least a portion of the proximal end 142 of the at least one syringe 132. In some examples, the frame 154 may be shaped to receive at least a portion of the proximal end 142 of each syringe 132. In some examples, the fluid outlet line 152 may be connected to the frame 154. The frame 154, in some examples, defines at least a portion of the access port 192 for connecting a single-use disposable set to the MUDS 130. The frame 154 may have a handle for grasping the MUDS 130 during insertion into and removal from the fluid injector system 100. In certain examples, the access port 192 may be formed as part of or adhered/welded to the frame 154 to form a single MUDS 130 unit. The syringes 132 may be removably or non-removably connected to the frame 154. In certain examples, the at least one syringe 132 may be co-molded with the frame 154 or, alternatively, adhered or welded to frame 154.


With further reference to FIG. 3B, each syringe 132 has an elongated, substantially cylindrical syringe body 138 having a front or distal end 140 and a rear or proximal end 142. A syringe plunger 144 is disposed within the syringe body 138 and is reciprocally movable within the syringe body 138 due to movement of a piston element 103 associated with the fluid injector system 100. The distal end 140 of the syringe body 138 is generally conical-shaped and tapers to an apex or cone portion 145 which is adapted to interface with a corresponding apex curve formed in the recess defined in the fluid injector system 100, as described herein. The syringe apex or cone portion 145 is located along a central longitudinal axis L of the syringe body 138. Each syringe 132 has a discharge outlet or conduit 146 at the terminal end of the apex or cone portion 145. The discharge outlet 146 of each syringe 132 is in fluid communication with valve 136 which provides fluid communication with a manifold 148 and the bulk fluid connector 118. The manifold 148 may also provide support for the syringes 132 along with the frame 154 so the syringes 132 can be handled as a single, unitary structure. In some examples, the manifold 148 supports the distal end 140 of each syringe 132 while the frame 154 supports the proximal end 142 of each syringe 132. The syringes 132 may be arranged in a side-by-side orientation, or any other orientation that retains the relative positioning of the syringes 132.


As will be appreciated by one having ordinary skill in the art, it may be desirable to construct at least a portion of the MUDS 130 from a clear medical grade plastic in order to facilitate visual verification that a fluid connection has been established with the fluid injector system 100. Visual verification is also desirable for confirming that no air bubbles are present within various fluid connections. Alternatively, at least a portion of the MUDS 130 and/or door 116 may include windows (not shown) for visualization of the connection between various components. Various optical sensors (not shown) may also be provided to detect and verify the connections. Additionally, various lighting elements (not shown), such as light emitting diodes (LEDs) may be provided to actuate one or more optical sensors and indicate that a suitable connection has been established between the various components.


With specific reference to FIG. 2, a schematic view of various fluid paths of the fluid injector system 100 is provided. The MUDS 130 may include one or more valves 136, such as stopcock valves, for controlling which medical fluid or combinations of medical fluids are withdrawn from the multi-dose bulk fluid source 120 and/or are delivered to a patient through each syringe 132. In some examples, the one or more valves 136 may be provided on the distal end 140 of the plurality of syringes 132 or on the manifold 148. The manifold 148 may be in fluid communication via valves 136 and/or syringes 132 with a first end of the MUDS fluid path 134 that connects each syringe 132 to the corresponding bulk fluid source 120. The opposing second end of the MUDS fluid path 134 may be connected to the respective bulk fluid connector 118 that is configured for fluidly connecting with the bulk fluid source 120. Depending on the position of the one or more valves 136, fluid may be drawn into the one or more syringes 132, or it may be delivered from the one or more syringes 132. In a first position, such as during the filling of the syringes 132, the one or more valves 136 are oriented such that fluid flows from the bulk fluid source 120 into the desired syringe 132 through a fluid inlet line 150, such as a MUDS fluid path. During the filling procedure, the one or more valves 136 are positioned such that fluid flow through one or more fluid outlet lines 152 or manifold 148 is blocked. In a second position, such as during a fluid delivery procedure, fluid from one or more syringes 132 is delivered to the manifold 148 through the one or more fluid outlet lines 152 or syringe valve outlet ports. During the delivery procedure, the one or more valves 136 are positioned such that fluid flow through one or more fluid inlet lines 150 is blocked. The one or more valves 136, fluid inlet lines 150, and/or fluid outlet lines 152 may be integrated into the manifold 148. The one or more valves 136 may be selectively positioned to the first or second position by manual or automatic handling. For example, the operator may position the one or more valves 136 into the desired position for filling or fluid delivery. In other examples, at least a portion of the fluid injector system 100 is operable for automatically positioning the one or more valves 136 into a desired position for filling or fluid delivery based on input by the operator.


Referring again to FIG. 2, in some examples, the fluid outlet line 152 may also be connected to a waste reservoir 156 on the fluid injector system 100. The waste reservoir 156 is desirably separate from the syringes 132 to prevent contamination. In some examples, the waste reservoir 156 is configured to receive waste fluid expelled from the syringes 132 during, for example, a priming operation. The waste reservoir 156 may be removable from the housing 102 in order to dispose of the contents of the waste reservoir 156. In other examples, the waste reservoir 156 may have a draining port (not shown) for emptying the contents of the waste reservoir 156 without removing the waste reservoir 156 from the housing 102. In some examples, the waste reservoir 156 is provided as a separate component from the MUDS 130.


With the foregoing description of the fluid injector system 100 and the MUDS 130 in mind, exemplary loading of the MUDS 130 into a receiving space 158 (shown in FIG. 3A) on the housing 102 will now be described with reference to FIGS. 3A-4C. In the following discussion, it is assumed that the MUDS 130 may be connected to the fluid injector system 100 for use with a single patient or multiple patients. Referring initially to FIG. 3A, the receiving space 158 has a bottom plate 160 separated from a top plate 162 by a rear sidewall 164. The bottom plate 160 has a plurality of openings 166 through which the piston elements 103 (shown in FIG. 2) of the fluid injector system 100 extend to engage the respective plungers 144 of the MUDS 130. At least one bottom guide 168 is formed on the bottom plate 160 for guiding the frame 154 of the MUDS 130 as the MUDS 130 is loaded into the fluid injector system 100. In some examples, the bottom guide 168 may be configured as a pair of walls raised relative to the bottom plate 160 and narrowing in an insertion direction toward the rear sidewall 164. During insertion, the bottom guide 168 defines a guiding surface that locates the frame 154 of the MUDS 130 and guides the frame 154 toward the rear sidewall 164 of the receiving space 158. In this manner, the MUDS 130 can be aligned into the receiving space 158 even when MUDS 130 is initially misaligned with receiving space 158.


With reference to FIG. 3B, and with continued reference to FIG. 3A, the top plate 162 is configured to receive the distal end 140 of the at least one syringe 132. The top plate 162 has one or more syringe slots 170 (shown in FIG. 3A) that are shaped to receive at least a portion of the distal end 140 of the syringes 132. In some examples, when the MUDS 130 is inserted into the receiving space 158, the syringe slots 170 of the top plate 162 may be disposed between the distal end 140 of the at least one syringe 132 and the manifold 148. The top plate 162 may be rotatable about a pivot point P1 (shown in FIG. 3B) or it may be movable in a vertical direction relative to the MUDS 130. In a first position, such as during loading of the MUDS 130 into the receiving space 158, the top plate 162 may be raised such that the apex or cone portion 145 of the at least one syringe 132 clears a lower surface of the top plate 162. In some examples, the top plate 162 can default to the first position each time the MUDS 130 is removed from the receiving space 158, such as by a biasing mechanism. In other examples, the top plate 162 can be urged to the first position as the apex or cone portion 145 of the at least one syringe 132 engages the at least one syringe slot 170.


As the MUDS 130 engages the rear sidewall 164, such as shown in FIG. 4A, the MUDS 130 can be locked in the receiving space 158 by moving the top plate 162 to a second position. In the second position, the top plate 162 is lowered such that the apex or cone portion 145 of the at least one syringe 132 engages the lower surface of the top plate 162. In some examples, the top plate 162 can be urged to the second position by a biasing mechanism (not shown). In other examples, the top plate 162 can be manually moved to the second position by pivoting the top plate 162 in a direction of arrow A shown in FIGS. 4A-4B. The top plate 162 can be locked relative to the MUDS 130 to prevent removal of the MUDS 130 from the receiving space 158 by a latch 172. The latch 172 may be operable to prevent the top plate 162 from rotating about the pivot point P1. The latch 172 may be a spring-loaded latch that is pivotable about a pivot point P2 in a direction of arrow B shown in FIG. 4B. In some examples, the latch 172 may be an over-center, spring-loaded latch that is pivotable about a pivot point P2. With reference to FIG. 4C, when the MUDS 130 is locked within the receiving space 158, the lower surface of the top plate 162 engages the apex or cone portion 145 of the at least one syringe 132. In the locked position, the longitudinal axis L of each syringe 132 is aligned with a center of each syringe slot 170. Removal of the MUDS 130 from the receiving space 158 when the top plate 162 is in the locked position is prevented by the engagement of the lower surface of the top plate 162 with the apex or cone portion 145 of the at least one syringe 132. Once locked, the top plate 162 substantially retains the syringes 132 from moving axially during an injection procedure.


With reference to FIGS. 5 and 6A, according to one example of the disclosure, the syringes 132 used in the MUDS 130 may include a stabilizing element 180 provided on the distal end 140 of each syringe 132. In this example shown in FIG. 5, another configuration of the MUDS 130 includes a plurality of bulk fluid connectors 118, a frame 154, a plurality of valves 136 provided on a manifold 148, a fluid path 134 between each valve 136 and the bulk fluid connectors 118, and a fluid outlet line 152. The stabilizing element 180 may extend around at least a portion of the distal end 140 of each syringe 132. In another example, the stabilizing element 180 may extend around at least a portion of the distal end 140 of the syringe 132 around the longitudinal axis L. It is contemplated that the stabilizing element 180 may be continuous around the entire circumference or may include a plurality of separate sections isolated by spaces that are defined between each section. The stabilizing element 180 may be positioned at a proximal end of the cone portion 145 of the syringe 132 or any part of the cone portion 145 up to the nozzle 147. In this example, the stabilizing element 180 may have an inner diameter that substantially corresponds to the outer diameter of the syringe body 138. The stabilizing element 180 may be a ring that is formed integrally with the syringe body 138 or may be removably or non-removably attached to the syringe body 138, such as by adhesive, interference fit, welding, or other mechanical connections. The stabilizing element 180 may have a substantially planar upper surface 182 and a substantially planar bottom surface 184. In one example, the upper surface 182 may extend substantially perpendicular to the longitudinal axis L of the syringe 132. The planar upper surface 182 is provided to stabilize the syringe 132 when the top plate 162 of the fluid injector system 100 is closed on the distal end 140 of the syringe 132 to lock the MUDS 130 within the fluid injector system 100. In this manner, the upper surface 180 is oriented substantially perpendicular to the longitudinal axis of the movable piston element 103 such that the movable piston element 103 does not impart a radially oriented force on the syringe 132. The stabilizing element 180 may be made of the same material as the syringe 132. In one example, stabilizing element 180 may be made of a transparent, medical-grade plastic.


During insertion of the MUDS 130 into the fluid injector system 100, the top plate 162 is rotated downwards to bring the syringe slots 170 into engagement with the syringes 132 in the MUDS 130. As can often occur during the insertion procedure, the top plate 162 may contact the distal ends 140 of the syringes 132 and position the syringes 132 such that the longitudinal axis L of the syringe 132 is out of alignment with the longitudinal axis of the movable piston elements 103. The top plate 162 may contact the cone portion 145 of the syringes 132 and push the syringes 132 into an off-center position such that the syringes 132 are angled relative to the longitudinal axis of the movable piston elements 103. Due to the angled surface of the cone portion 145 of the syringes 132, syringe slots 170, and resulting forces from fluid delivery (fluid pressure), the top plate 162 may move the syringes 132 away from a desired operating position. For example, when the piston plunger assembly of one or more of the syringes is 132 is moved in a distal direction, such as during a fluid delivery process, the pressure one the fluid and syringes may shift the MUDS to an off-center or tilted position resulting in potential fluid leakage or “blow by” between the circumferential rim of the plunger and the inner syringe wall. To avoid or correct the potential tendency for the MUDS unit to be forced out of alignment with the longitudinal axis, the stabilizing element 180 of the distal end 140 of each syringe 132 ensures that the top plate 132 rests on a planar or flat surface to assure alignment of the longitudinal axis L of the syringe 132 with the longitudinal axis of the movable piston elements 103. As the top plate 162 is rotated downwards towards the syringes 132, the top plate 162 may contact the stabilizing element 180, which provides a flat, planar surface that provides an increased surface area for the top plate 162 to contact.


With reference to FIG. 6B, another example of the stabilizing element 186 is shown on a syringe 132. In this example, the stabilizing element 186 may be a sleeve that is formed or provided around the body 138 (covered in FIG. 6B by the stabilizing element 186) of the syringe 132. The stabilizing element 186 may be formed integrally with the body 138, may be removably or non-removably attached to the body 138, such as by adhesion, welding, or friction fit with the body 138. The stabilizing element 186 may include a planar upper surface 188 upon which the top plate 162 of the fluid injector system 100 may contact when the MUDS 130 has been inserted into the fluid injector system 100. In one example, the upper surface 188 may extend substantially perpendicular to the longitudinal axis L of the syringe 132. The stabilizing element 186 may be substantially cylindrical with an inner diameter that is slightly greater than the outer diameter of the body 138. In another example, the inner diameter of the stabilizing element 186 may be slightly smaller than the outer diameter of the body 138, but may be resilient to form a friction fit with the body 138. A distal end of the stabilizing element 186 may be positioned adjacent to the cone portion 145 of the syringe 132. A proximal end of the stabilizing element 186 may contact a flange 190 provided on the proximal end 142 of the syringe 132. The stabilizing element 186 may be made of the same material as the syringe 132. In one example, the stabilizing element 186 may be made of a transparent, medical-grade plastic. Similar to the stabilizing element 180 shown in FIG. 6A, the stabilizing element 186 may be provided on the syringe 132 to stabilize the syringe 132 upon insertion of the MUDS 130 into the fluid injector system 100. The top plate 162 of the fluid injector system 100 may contact the planar upper surface 188 of the stabilizing element 186 to hold the syringe 132 in an upright, centered position relative to the fluid injector system 100. In another example, the stabilizing element 186 may be a part of the syringe body 138 of the syringe 132, extending axially along the longitudinal axis L, protruding from the cone portion 145 of the syringe 132.


With reference to FIG. 6C, another example of the stabilizing element 193 is shown on a syringe 132. The stabilizing element 193 may include a substantially planar member 194 and a plurality of webs 196 that connect the stabilizing element 193 to the syringe 132. The planar member 194 may include an upper surface that extends substantially perpendicular to the longitudinal axis L of the syringe 132. An inner circumferential surface of the planar member 194 may be integrally (i.e., monolithically) formed on or removably or non-removably attached to the cone portion 145 of the syringe 132. It is also contemplated that the inner circumferential surface of the planar member 194 may not be connected to the syringe 132, but may contact the cone portion 145 of the syringe 132. A bottom surface of each web 196 may be integrally formed on the syringe 132 or may be removably or non-removably attached to the syringe 132. An upper surface of each web 196 may be integrally formed on or remoavbly or non-removably connected to a bottom surface of the planar member 194. In one example, the webs 196 may be triangular in shape. The stabilizing element 193 may be made of the same material as the syringe 132. In one example, the stabilizing element 193 may be made of a transparent, medical-grade plastic. Similar to the stabilizing element 180 shown in FIG. 6A, the stabilizing element 193 may be provided on the syringe 132 to stabilize the syringe 132 within the MUDS 130 upon insertion of the MUDS 130 into the fluid injector system 100. The top plate 162 of the fluid injector system 100 may contact the planar member 194 of the stabilizing element 193 to hold the syringe 132 in an upright, centered position relative to the fluid injector system 100.


With reference to FIG. 6D, another example of a stabilizing element 198 is shown on a syringe 132. The stabilizing element 198 is similar to the webs 196 depicted in FIG. 6C. In one example, at least two stabilizing elements 198 may be provided on the syringe 132. It is also contemplated that a plurality of stabilizing elements 198 may be provided around the outer circumferential surface of the syringe 132. The stabilizing element 198 is substantially triangular and includes a bottom surface 200 that is formed integrally with or adhesively attached to the cone portion 145 of the syringe 132. The stabilizing element 198 may have a planar upper surface 202 that extends outwardly from the cone portion 145. The upper surface 202 may extend perpendicular to the longitudinal axis L of the syringe 132. The stabilizing element 198 may be made of the same material as the syringe 132. In one example, the stabilizing element 198 may be made of a transparent, medical-grade plastic. Similar to the stabilizing element 180 shown in FIG. 6A, the stabilizing element 198 may be provided on the syringe 132 to stabilize the syringe 132 upon insertion of the MUDS 130 into the fluid injector system 100. The top plate 162 of the fluid injector system 100 may contact the upper surface 202 of the stabilizing element 198 to hold the syringe 132 in an upright, centered position relative to the fluid injector system 100.


With reference to FIG. 6E, another example of a stabilizing element 204 is shown on a syringe 132. In one example, at least two stabilizing elements 204 may be provided on the syringe 132. In another example, more than two stabilizing elements 204 may be provided on the syringe 132. It is also contemplated that the stabilizing element 204 may extend around the entire outer circumferential surface of the cone portion 145 of the syringe 132. The stabilizing element 204 may include a planar member 206 and a plurality of webs 208 provided to connect the planar member 206 to the syringe 132. The stabilizing element 204 may be integrally formed on or removably or non-removably attached to the syringe 132. The stabilizing element 204 may be provided entirely on the cone portion 145 of the syringe 132. The planar member 206 may include an upper surface that extends substantially perpendicular to the longitudinal axis L of the syringe 132. The planar member 206 may be positioned adjacent the discharge conduit 146 of the syringe 132. An inner circumferential surface of the planar member 206 may be integrally formed on or removably or non-removably attached to the cone portion 145 of the syringe 132. It is also contemplated that the inner circumferential surface of the planar member 206 may not be connected to the syringe 132, but may contact the cone portion 145 of the syringe 132. A bottom surface of each web 208 may be integrally formed on the syringe 132 or may be removably or non-removably attached to the syringe 132. An upper surface of each web 208 may be integrally formed on or removably or non-removably connected to a bottom surface of the planar member 206. In one example, the webs 208 may be triangular in shape. The stabilizing element 204 may be made of the same material as the syringe 132. In one example, the stabilizing element 204 may be made of a transparent, medical-grade plastic. Similar to the stabilizing element 180 shown in FIG. 6A, the stabilizing element 204 may be provided on the syringe 132 to stabilize the syringe 132 within the MUDS 130 upon insertion of the MUDS 130 into the fluid injector system 100. The top plate 162 of the fluid injector system 100 may contact the planar member 206 of the stabilizing element 204 to hold the syringe 132 in an upright, centered position relative to the fluid injector system 100.



FIGS. 7A, 7B illustrate an embodiment of the top side and the bottom side of the top plate 162. Referring first to FIG. 7A, top plate 162 has a bottom surface 240 and three syringe slots 170 for receiving the distal ends of syringes 132. Each syringe slot 170 has an interior conical portion 245 and stabilizing element contact surface 250 and an optional recessed surface 260. The stabilizing element contact surface 250 has a surface perpendicular to the longitudinal axis L of the MUDS when the top plate 162 is in the inserted and locked position, such that the stabilizing element contact surface 250 is in flush surface-to-surface contact with the planar upper surface (182, 188, 194, 202, or 206) of the stabilizing element 180, 193, 186, 198, or 204, respectively). The flush surface-to-surface contact between the stabilizing element contact surface 250 and the planar upper surface prevents tilting or off-center alignment of the MUDS relative the longitudinal axis of the piston path. Optional recessed surface 260 comprises a recessed area relative to the stabilizing element contact surface 250 near the back side of top plate 162 and prevents contact with the syringe stabilizing element during the loading process as the top plate 162 is lowered to engage the MUDS. This may allow for balanced loading of the syringe stabilizing element without displacing or miss-aligning the MUDS as the top plate 162 is lowered due to contact between the stabilizing element upper surface and the rear portion of syringe slot 170. Referring to FIG. 7B, a top surface 230 of top plate 162 is illustrated. Syringe slots 170 can be seen along with recessed surfaces 260 at the rear portion of syringe slots 170. The edge of the stabilizing element contact surface 250 may be seen near the front of syringe slots 170.


While several examples of multi-use disposable sets and syringes therefor are shown in the accompanying figures and described hereinabove in detail, other examples will be apparent to, and readily made by, those skilled in the art without departing from the scope and spirit of the disclosure. For example, it is to be understood that this disclosure contemplates that, to the extent possible, one or more features of any example can be combined with one or more features of any other example. Accordingly, the foregoing description is intended to be illustrative rather than restrictive.

Claims
  • 1. A multi-use disposable set (MUDS) comprising: a plurality of syringes, each syringe having a syringe body, a proximal end, a distal end spaced apart from the proximal end along a longitudinal axis of the syringe body, a cone portion and a nozzle extending distally from the distal end of the syringe body, and a stabilizing element provided on the distal end, the cone portion being monolithically formed with the syringe body, the stabilizing element comprising a continuous ring that extends around an entire outer circumferential surface of a proximal end of the cone portion on the distal end, the stabilizing element having an engagement surface extending substantially perpendicular to the longitudinal axis of the syringe body, wherein the engagement surface is configured to stabilize a vertical alignment of each syringe of the plurality of syringes when a planar surface of a top plate of a fluid injector system defining at least one syringe slot is moved into a closed position to contact the engagement surface of each of the syringes, wherein an outer diameter of the stabilizing element is greater than an outer diameter of the syringe body, and wherein the stabilizing element is integrally formed on the syringe body;a frame for receiving at least a portion of the proximal end of each syringe of the plurality of syringes prior to the top plate of the fluid injector system being moved into engagement with the engagement surface of each syringe, and for loading into a bottom guide of the fluid injector to align the MUDS in a receiving space of the fluid injector; anda manifold in fluid communication with the distal end of each syringe of the plurality of syringes.
  • 2. The MUDS of claim 1, wherein each engagement surface is configured to provide a stable verticle alignment of the respective syringe with a corresponding movable piston element of the fluid injector system as a planar surface on the top plate of the fluid injector system contacts the stabalizing element.
CROSS REFERENCE TO RELATED APPLICATION

This application is a 371 national phase application of PCT International Application No. PCT/US2017/036941, filed Jun. 12, 2017, and claims the benefit of U.S. Provisional Patent Application No. 62/350,487 titled MULTI-USE DISPOSABLE SYSTEM AND SRYINGE THEREFOR, filed Jun. 15, 2016, the disclosures of which are incorporated herein by reference in their entirety.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2017/036941 6/12/2017 WO
Publishing Document Publishing Date Country Kind
WO2017/218372 12/21/2017 WO A
US Referenced Citations (196)
Number Name Date Kind
926755 Nathaniel Jul 1909 A
2287746 Morton Jun 1942 A
2731053 Lockhart Jan 1956 A
2780243 Williams et al. Feb 1957 A
2798487 Ferguson Jul 1957 A
2938238 Gewecke et al. May 1960 A
2997043 Flynn Aug 1961 A
3164279 Towns Jan 1965 A
3658061 Hall Apr 1972 A
3835862 Villari Sep 1974 A
3909910 Rowe et al. Oct 1975 A
3985133 Jenkins et al. Oct 1976 A
3986508 Barrington Oct 1976 A
3987930 Fuson Oct 1976 A
4019512 Tenczar Apr 1977 A
4022205 Tenczar May 1977 A
4106654 Jones Aug 1978 A
4123091 Cosentino et al. Oct 1978 A
4187846 Carminucci et al. Feb 1980 A
4194509 Ferguson et al. Mar 1980 A
4227615 Flick Oct 1980 A
4230231 Burnett et al. Oct 1980 A
4340148 Beckham Jul 1982 A
4360969 Collier Nov 1982 A
4366816 Bayard et al. Jan 1983 A
4369779 Spencer Jan 1983 A
4396385 Kelly et al. Aug 1983 A
4398757 Floyd et al. Aug 1983 A
4402420 Chernack Sep 1983 A
4433973 Kurtz et al. Feb 1984 A
4450624 Collier May 1984 A
4482347 Borsanyi Nov 1984 A
4511359 Vaillancourt Apr 1985 A
4551146 Rogers Nov 1985 A
4559043 Whitehouse et al. Dec 1985 A
4579823 Ryder Apr 1986 A
4624664 Peluso et al. Nov 1986 A
4636204 Christopherson et al. Jan 1987 A
4687472 Gross Aug 1987 A
4723945 Theiling Feb 1988 A
4775369 Schwartz Oct 1988 A
4778447 Velde et al. Oct 1988 A
4795426 Jones Jan 1989 A
4810241 Rogers Mar 1989 A
4828557 Persidsky May 1989 A
4854836 Borsanyi Aug 1989 A
4883641 Wicks et al. Nov 1989 A
4950260 Bonaldo Aug 1990 A
4981469 Whitehouse et al. Jan 1991 A
5049047 Polaschegg et al. Sep 1991 A
5057088 Narayanan et al. Oct 1991 A
5088984 Fields Feb 1992 A
5098395 Fields Mar 1992 A
5102253 Pugliesi-Conti et al. Apr 1992 A
5171229 McNeil et al. Dec 1992 A
5184742 Decaprio et al. Feb 1993 A
5213483 Flaherty et al. May 1993 A
5221267 Folden Jun 1993 A
5251873 Atkinson et al. Oct 1993 A
5280809 Tive Jan 1994 A
5281111 Plambeck et al. Jan 1994 A
5292308 Ryan Mar 1994 A
5340359 Segura Badia Aug 1994 A
5382242 Horton et al. Jan 1995 A
5413280 Taylor May 1995 A
5482171 Palmer Jan 1996 A
5494036 Uber, III et al. Feb 1996 A
5498253 Aswad et al. Mar 1996 A
5551850 Williamson et al. Sep 1996 A
5569181 Heilman et al. Oct 1996 A
5620433 Aswad et al. Apr 1997 A
5739508 Uber, III Apr 1998 A
5746718 Steyn May 1998 A
5779675 Reilly et al. Jul 1998 A
5785691 Vetter et al. Jul 1998 A
5803510 Dorsey, III et al. Sep 1998 A
5806519 Evans, III et al. Sep 1998 A
5840026 Uber, III et al. Nov 1998 A
5843037 Uber, III Dec 1998 A
5853096 Bartur et al. Dec 1998 A
5873861 Hitchins et al. Feb 1999 A
5913434 Fukuhara et al. Jun 1999 A
5916197 Reilly et al. Jun 1999 A
5934496 Mogard et al. Aug 1999 A
5964583 Danby Oct 1999 A
5972292 Demeo Oct 1999 A
6077259 Caizza et al. Jun 2000 A
6113068 Ryan Sep 2000 A
6123686 Olsen et al. Sep 2000 A
6164279 Tweedle Dec 2000 A
6261270 Gault et al. Jul 2001 B1
6306117 Uber, III Oct 2001 B1
6339718 Zatezalo et al. Jan 2002 B1
6428518 Brengle et al. Aug 2002 B1
6436072 Kullas et al. Aug 2002 B1
6511472 Hayman et al. Jan 2003 B1
6616000 Renz Sep 2003 B1
6666839 Utterberg et al. Dec 2003 B2
6669681 Jepson et al. Dec 2003 B2
6679529 Johnson et al. Jan 2004 B2
6814726 Lauer Nov 2004 B1
6821267 Veillon et al. Nov 2004 B2
6869425 Briggs et al. Mar 2005 B2
6911025 Miyahara Jun 2005 B2
6981960 Cho et al. Jan 2006 B2
7022256 Uegami et al. Apr 2006 B2
7040598 Raybuck May 2006 B2
7070589 Ebner et al. Jul 2006 B2
7083605 Miyahara Aug 2006 B2
7097209 Unger et al. Aug 2006 B2
7241285 Dikeman Jul 2007 B1
7252308 Thilly Aug 2007 B2
7361156 Joyce Apr 2008 B2
7374555 Heinz et al. May 2008 B2
7452349 Miyahara et al. Nov 2008 B2
7481795 Thompson et al. Jan 2009 B2
7569047 Utterberg Aug 2009 B2
7618412 Chernack Nov 2009 B2
7713250 Harding et al. May 2010 B2
7731155 Funamura et al. Jun 2010 B2
7740288 Mantell Jun 2010 B2
7918243 Diodati et al. Apr 2011 B2
7938454 Buchanan et al. May 2011 B2
8007487 Patrick et al. Aug 2011 B2
8012144 Moberg Sep 2011 B2
8038667 Racz et al. Oct 2011 B2
8062009 Cueni Nov 2011 B2
8133035 Wolff Mar 2012 B2
8140274 Gagel et al. Mar 2012 B2
8147464 Spohn et al. Apr 2012 B2
8157547 Oude et al. Apr 2012 B2
8257267 Thornton Sep 2012 B2
8287724 Slepicka et al. Oct 2012 B2
8308456 Moubayed Nov 2012 B2
8343128 Nagao et al. Jan 2013 B2
8360757 Knauper et al. Jan 2013 B2
8425463 Patrick et al. Apr 2013 B2
8545440 Patrick et al. Oct 2013 B2
8852162 Williams et al. Oct 2014 B2
9044542 Patrick et al. Jun 2015 B2
9358333 Trombley, III et al. Jun 2016 B2
9393441 Hoffman et al. Jul 2016 B2
9408971 Carlyon et al. Aug 2016 B2
9566381 Barron et al. Feb 2017 B2
10046106 Cowan et al. Aug 2018 B2
20010016704 Zadno-Azizi et al. Aug 2001 A1
20020010437 Lopez et al. Jan 2002 A1
20020093192 Matkovich Jul 2002 A1
20040122369 Schriver et al. Jun 2004 A1
20050090805 Shaw et al. Apr 2005 A1
20050199304 Poppe et al. Sep 2005 A1
20050267418 Fournie et al. Dec 2005 A1
20070049870 Gray et al. Mar 2007 A1
20070088271 Richards Apr 2007 A1
20070100282 Small May 2007 A1
20080045925 Stepovich et al. Feb 2008 A1
20080071219 Rhinehart et al. Mar 2008 A1
20080071220 Rhinehart et al. Mar 2008 A1
20080097342 Gordin Apr 2008 A1
20080177250 Howlett et al. Jul 2008 A1
20080287872 Patzer Nov 2008 A1
20090102192 Ziman Apr 2009 A1
20090105629 Grant et al. Apr 2009 A1
20090182309 Muffly Jul 2009 A1
20090216192 Schriver et al. Aug 2009 A1
20100022988 Wochner et al. Jan 2010 A1
20100049170 Solomon et al. Feb 2010 A1
20100056975 Dale et al. Mar 2010 A1
20100113924 Hajicek et al. May 2010 A1
20100116365 McCarty May 2010 A1
20100130918 Elahi May 2010 A1
20100130922 Borlaug et al. May 2010 A1
20100286467 Pesach et al. Nov 2010 A1
20100305508 Franks et al. Dec 2010 A1
20110049866 Trombley, III et al. Mar 2011 A1
20110054440 Lewis Mar 2011 A1
20110196291 Vischer et al. Aug 2011 A1
20110240158 Py Oct 2011 A1
20110282302 Lopez et al. Nov 2011 A1
20110313394 Bobo, Sr. Dec 2011 A1
20120116317 Kassab et al. May 2012 A1
20120123257 Stokes, Jr. May 2012 A1
20120148415 Brueckner et al. Jun 2012 A1
20130079581 Agamaite et al. Mar 2013 A1
20130123567 Agamaite et al. May 2013 A1
20130131579 Mantell et al. May 2013 A1
20130211248 Cowan Aug 2013 A1
20130245565 Leak Sep 2013 A1
20130331634 Kaintz et al. Dec 2013 A1
20140107480 Spohn et al. Apr 2014 A1
20140224829 Capone et al. Aug 2014 A1
20140296786 Servansky Oct 2014 A1
20140342447 Aviles et al. Nov 2014 A1
20150174338 Takemoto Jun 2015 A1
20170056603 Cowan et al. Mar 2017 A1
20170266373 Pananen Sep 2017 A1
Foreign Referenced Citations (33)
Number Date Country
1126117 Jun 1982 CA
3838689 Jun 1990 DE
4037797 Feb 1992 DE
102013104018 Oct 2014 DE
0204977 Dec 1986 EP
0503670 Sep 1992 EP
1331020 Jul 2003 EP
2409720 Jan 2012 EP
1834664 May 2013 EP
2594496 Aug 1987 FR
2847342 May 2004 FR
2020735 Nov 1979 GB
2003210574 Jul 2003 JP
9103404 Mar 1991 WO
9714493 Apr 1997 WO
9806446 Feb 1998 WO
0202164 Jan 2002 WO
0204049 Jan 2002 WO
02096487 Dec 2002 WO
03039646 May 2003 WO
03044488 May 2003 WO
2005110007 Nov 2005 WO
2008086631 Jul 2008 WO
2008141337 Nov 2008 WO
2009067200 May 2009 WO
2009149367 Dec 2009 WO
2012170961 Dec 2012 WO
2013043868 Mar 2013 WO
2013043881 Mar 2013 WO
2013059563 Apr 2013 WO
2013104665 Jul 2013 WO
WO-2015058088 Apr 2015 WO
WO2015-066506 May 2015 WO
Non-Patent Literature Citations (28)
Entry
Asepti-Quik S Connector Catalog, May 2010.
AseptiQuik X Connector Catalog, Oct. 2012.
Catalog Valves, http://www.minivalve.com/newsite/index.php/en/home—last visited Sep. 23, 2016.
COLDER; Products Company., “Asepti-Quik Product Catalog”, accessed online on Oct. 11, 2013.
Connection Solutions for Biopharmaceutical Processes, May 2012.
DoseGuard Valved Bottle Adapter System Brochure.
“Extended European Search Report and Written Opinion from EP14810311”, dated Nov. 22, 2016.
“Extended European Search Report from EP App. No. 16735394”, dated Dec. 11, 2018.
Hadaway; Lynn, “Needleless Connectors: A Primer on Terminology”, Journal of Infusion Nursing, Jan./Feb. 2010, 33(1), 22-31.
“International Preliminary Report on Patentability and Written Opinion from PCT Application No. PCT/US2012/060978”, dated Apr. 22, 2014.
“International Preliminary Report on Patentability from PCT Application No. PCT/US2015/010825”, dated Jul. 21, 2016.
“International Preliminary Report on Patentability from PCT Application No. PCT/US2017/036941”, dated Dec. 27, 2018.
International Preliminary Report on Patentability, Written Opinion, and International Search Report from PCT/US2014/042310 dated Dec. 15, 2015.
“International Search Report and Written Opinion from corresponding PCT App. No. PCT/US2015/010825”, dated Apr. 10, 2015.
“International Search Report and Written Opinion from PCT Application No. PCT/US2014/044500”, dated Nov. 4, 2014.
“International Search Report and Written Opinion from PCT Application No. PCT/US2017/036941”, dated Sep. 12, 2017.
“International Search Report from PCT Application No. PCT/US2012/060978”, dated Feb. 5, 2013.
“International Search Report in PCT Application No. PCT/US2014/044500”, dated Nov. 4, 2014.
Pure Fit SC True Sterile Connections . . . Outside the Clean Room Catalog, Saint-Gobain Performance Plastics. 2008.
ReadyMate Disposable Aseptic Connectors, Operation Manual, Jul. 2009.
Single-Use Bags 50 to 500 Liters Catalog, Jun. 2010.
Site-Scrub IPA Device—last visited Sep. 23, 2016.
TAKEONE Aseptic Sampling System Brochure, 2010.
UFP; Technologies., “BioShell Suspension Pack Brochure”, accessed online on May 7, 2013.
“ULTRAPORT Swabbable Port Stopcocks, B. Braun Sharing Expertise.”, accessed online on Apr. 14, 2014.
“Supplementary European Search Report from EP Application No. 15735396”, dated Jun. 28, 2017.
“Supplementary European Search Report from EP Application No. EP12842335.”, dated Feb. 16, 2015.
“Written Opinion and International Search Report from PCT Application No. PCT/US2016/012434”, dated May 6, 2016.
Related Publications (1)
Number Date Country
20200268980 A1 Aug 2020 US
Provisional Applications (1)
Number Date Country
62350487 Jun 2016 US